CuraleafCuraleaf Holdings Inc. (OTC: CURLF) is a cannabis holding company focused on medical products. Its operations cover the cultivation, processing, and dispensing of legal cannabis. With expanded legalization in the United States, this stock is well-positioned to grow in the coming years.

In its third quarter fiscal report, Curaleaf announced managed revenue of $193.2 million, an increase of 164% year over year. The company also generated a positive EBITDA of $42.3 million from its operations across 23 states.

Curaleaf is a promising cannabis stock because of its widespread business in America. It operates 30 processing sites, 22 cultivation sites, and 95 dispensaries, giving it access to the majority of the legal medical cannabis market. 37 states have now legalized medical cannabis, giving Curaleaf the option to expand its operations in 2021.

The company has now generated positive EBITDA for five straight quarters, and it is close to generating GAAP profitability. An upside is expected with a target price of $15.11, making this one of the best bargain pot stocks on the market today.

Key Data:

  • 1 Year Price Growth: 69%
  • YTD Price Growth: 39%
  • 3 Month Price Growth: 17%

All information is based on current and historical market data, as well as publicly available financial data. As with any financial decision, your own research is important. Stock market outcomes can never be 100% accurately predicted. Familiarity with historical data, individual industries, and individual stocks is key to developing a robust portfolio. Note that stock prices can fluctuate rapidly during trading sessions.